Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, Alan Valaperti, Jens Schreiner, Aline Wolfensberger, Miro E. Raeber, Sarah Adamo, Sebastian Weigang, Marc Emmenegger, Sara Hasler, Philipp P. Bosshard, Elena De Cecco, Esther Bächli, Alain Rudiger, Melina Stüssi‐Helbling, Lars C Huber, Annelies S. Zinkernagel, Dominik J. Schaer, Adriano Aguzzi, Georg Kochs, Ulrike Held, Elsbeth Probst‐Müller, Silvana K. Rampini, Onur Boyman
Topics & Concepts
MedicineTiterAntibodyImmunologyAntibody titerSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusImmunoglobulin AImmunoglobulin GNeutralizing antibodySeverity of illnessCoronavirus disease 2019 (COVID-19)DiseaseVirologyInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19